The Effect of Vorinostat on HIV RNA Expression in the Resting CD4+ T Cells of HIV+ Pts on Stable ART
Clinical trial NCT01319383 · COMPLETED
Trial details
- NCT number
- NCT01319383
- Sponsor
- University of North Carolina, Chapel Hill
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2016-03-31
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.